<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>metabolic dysfunction-associated steatohepatitis &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/metabolic-dysfunction-associated-steatohepatitis/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 12:56:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>metabolic dysfunction-associated steatohepatitis &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Exploring Innovative Approaches to Treat Metabolic Dysfunction-Associated Fatty Liver Disease</title>
		<link>https://bioengineer.org/exploring-innovative-approaches-to-treat-metabolic-dysfunction-associated-fatty-liver-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 10 Mar 2025 21:26:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[FXR agonists in liver disease]]></category>
		<category><![CDATA[liver fibrosis mechanisms]]></category>
		<category><![CDATA[MAFLD treatment innovations]]></category>
		<category><![CDATA[metabolic dysfunction-associated steatohepatitis]]></category>
		<category><![CDATA[transcription factor-targeted therapies]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-innovative-approaches-to-treat-metabolic-dysfunction-associated-fatty-liver-disease/</guid>

					<description><![CDATA[Metabolic dysfunction-associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease (NAFLD), represents a significant global health challenge, affecting countless individuals and representing a spectrum of liver manifestations from benign steatosis to a more severe condition known as metabolic dysfunction-associated steatohepatitis (MASH). This disease progression is concerning as it can culminate in devastating [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">237998</post-id>	</item>
	</channel>
</rss>
